Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials
Author:
Funder
Guangxi Zhuang Region Health Department
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference36 articles.
1. Treatment of renal cell carcinoma: current status and future directions;Barata;CA Cancer J. Clin.,2017
2. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality;Jonasch;Nat. Rev. Nephrol.,2021
3. The landscape of iron metabolism-related and methylated genes in the prognosis prediction of clear cell renal cell carcinoma;Mou;Front. Oncol.,2020
4. Downregulation of human DAB2IP gene expression in renal cell carcinoma results in resistance to ionizing radiation;Yun;Clin. Cancer Res.,2019
5. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N. Engl. J. Med.,2007
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09
2. SEMA3G, downregulated by ncRNAs, correlates with favorable prognosis and tumor immune infiltration in kidney renal clear cell carcinoma;Aging;2023-12-08
3. Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis;World Journal of Urology;2023-04-26
4. C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients;Acta Oncologica;2022-07-29
5. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway;Molecular Cancer;2022-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3